Elisaf MS

References (12)

Title : Novel Hypolipidaemic Drugs: Mechanisms of Action and Main Metabolic Effects - Filippatos_2019_Curr.Vasc.Pharmacol_17_332
Author(s) : Filippatos TD , Liontos A , Christopoulou EC , Elisaf MS
Ref : Curr Vasc Pharmacol , 17 :332 , 2019
Abstract :
PubMedSearch : Filippatos_2019_Curr.Vasc.Pharmacol_17_332
PubMedID: 29424317

Title : The pharmacokinetic considerations and adverse effects of DDP-4 inhibitors - Filippatos_2014_Expert.Opin.Drug.Metab.Toxicol_10_787
Author(s) : Filippatos TD , Athyros VG , Elisaf MS
Ref : Expert Opin Drug Metab Toxicol , 10 :787 , 2014
Abstract :
PubMedSearch : Filippatos_2014_Expert.Opin.Drug.Metab.Toxicol_10_787
PubMedID: 24746233

Title : Small high-density lipoprotein (HDL) subclasses are increased with decreased activity of HDL-associated phospholipase A(2) in subjects with prediabetes - Filippatos_2013_Lipids_48_547
Author(s) : Filippatos TD , Rizos EC , Tsimihodimos V , Gazi IF , Tselepis AD , Elisaf MS
Ref : Lipids , 48 :547 , 2013
Abstract :
PubMedSearch : Filippatos_2013_Lipids_48_547
PubMedID: 23546765

Title : The effects of rosuvastatin alone or in combination with fenofibrate or omega 3 fatty acids on inflammation and oxidative stress in patients with mixed dyslipidemia - Agouridis_2011_Expert.Opin.Pharmacother_12_2605
Author(s) : Agouridis AP , Tsimihodimos V , Filippatos TD , Dimitriou AA , Tellis CC , Elisaf MS , Mikhailidis DP , Tselepis AD
Ref : Expert Opin Pharmacother , 12 :2605 , 2011
Abstract :
PubMedSearch : Agouridis_2011_Expert.Opin.Pharmacother_12_2605
PubMedID: 21714585

Title : Leptospirosis is associated with markedly increased triglycerides and small dense low-density lipoprotein and decreased high-density lipoprotein - Gazi_2011_Lipids_46_953
Author(s) : Gazi IF , Apostolou FA , Liberopoulos EN , Filippatos TD , Tellis CC , Elisaf MS , Tselepis AD
Ref : Lipids , 46 :953 , 2011
Abstract :
PubMedSearch : Gazi_2011_Lipids_46_953
PubMedID: 21688175

Title : Dose-dependent effect of rosuvastatin treatment on HDL-subfraction phenotype in patients with primary hyperlipidemia - Kostapanos_2009_J.Cardiovasc.Pharmacol.Ther_14_5
Author(s) : Kostapanos MS , Milionis HJ , Filippatos TD , Christogiannis LG , Bairaktari ET , Tselepis AD , Elisaf MS
Ref : J Cardiovasc Pharmacol Ther , 14 :5 , 2009
Abstract :
PubMedSearch : Kostapanos_2009_J.Cardiovasc.Pharmacol.Ther_14_5
PubMedID: 19246334

Title : Alterations in the high density lipoprotein phenotype and HDL-associated enzymes in subjects with metabolic syndrome - Lagos_2009_Lipids_44_9
Author(s) : Lagos KG , Filippatos TD , Tsimihodimos V , Gazi IF , Rizos C , Tselepis AD , Mikhailidis DP , Elisaf MS
Ref : Lipids , 44 :9 , 2009
Abstract :
PubMedSearch : Lagos_2009_Lipids_44_9
PubMedID: 18956219

Title : The effects of ezetimibe and orlistat, alone or in combination, on high-density lipoprotein (HDL) subclasses and HDL-associated enzyme activities in overweight and obese patients with hyperlipidaemia - Nakou_2008_Expert.Opin.Pharmacother_9_3151
Author(s) : Nakou ES , Filippatos TD , Kiortsis DN , Derdemezis CS , Tselepis AD , Mikhailidis DP , Elisaf MS
Ref : Expert Opin Pharmacother , 9 :3151 , 2008
Abstract :
PubMedSearch : Nakou_2008_Expert.Opin.Pharmacother_9_3151
PubMedID: 19040336

Title : Orlistat-associated adverse effects and drug interactions: a critical review - Filippatos_2008_Drug.Saf_31_53
Author(s) : Filippatos TD , Derdemezis CS , Gazi IF , Nakou ES , Mikhailidis DP , Elisaf MS
Ref : Drug Safety , 31 :53 , 2008
Abstract :
PubMedSearch : Filippatos_2008_Drug.Saf_31_53
PubMedID: 18095746

Title : Effect of paraoxonase 1 polymorphisms on the response of lipids and lipoprotein-associated enzymes to treatment with fluvastatin - Christidis_2007_Arch.Med.Res_38_403
Author(s) : Christidis DS , Liberopoulos EN , Kakafika AI , Miltiadous GA , Liamis GL , Kakaidi B , Tselepis AD , Cariolou MA , Elisaf MS
Ref : Arch Med Res , 38 :403 , 2007
Abstract :
PubMedSearch : Christidis_2007_Arch.Med.Res_38_403
PubMedID: 17416287

Title : Thyroid substitution therapy induces high-density lipoprotein-associated platelet-activating factor-acetylhydrolase in patients with subclinical hypothyroidism: a potential antiatherogenic effect - Milionis_2005_Thyroid_15_455
Author(s) : Milionis HJ , Tambaki AP , Kanioglou CN , Elisaf MS , Tselepis AD , Tsatsoulis A
Ref : Thyroid , 15 :455 , 2005
Abstract :
PubMedSearch : Milionis_2005_Thyroid_15_455
PubMedID: 15929667

Title : Alterations of paraoxonase and platelet-activating factor acetylhydrolase activities in patients on peritoneal dialysis - Liberopoulos_2004_Perit.Dial.Int_24_580
Author(s) : Liberopoulos EN , Papavasiliou E , Miltiadous GA , Cariolou M , Siamopoulos KC , Tselepis AD , Elisaf MS
Ref : Perit Dial Int , 24 :580 , 2004
Abstract :
PubMedSearch : Liberopoulos_2004_Perit.Dial.Int_24_580
PubMedID: 15559488